Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | metabotropic glutamate receptor 2 | 0.1885 | 0.6319 | 0.6319 |
Echinococcus multilocularis | histone deacetylase 6 | 0.0521 | 0.0648 | 0.0648 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.1097 | 0.3042 | 0.3335 |
Schistosoma mansoni | metabotropic glutamate receptor 2 3 (mglur group 2) | 0.2559 | 0.912 | 1 |
Brugia malayi | histone deacetylase 1 (HD1) | 0.0399 | 0.0141 | 0.018 |
Trypanosoma cruzi | histone deacetylase, putative | 0.0509 | 0.0597 | 1 |
Brugia malayi | Histone deacetylase 1 | 0.0399 | 0.0141 | 0.018 |
Echinococcus multilocularis | histone deacetylase 6 | 0.0509 | 0.0597 | 0.0597 |
Schistosoma mansoni | histone deacetylase hda2 | 0.0521 | 0.0648 | 0.071 |
Trichomonas vaginalis | histone deacetylase 1, 2 ,3, putative | 0.0399 | 0.0141 | 0.5 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0399 | 0.0141 | 0.5 |
Onchocerca volvulus | Poor gastrulation protein homolog | 0.0365 | 0 | 0.5 |
Echinococcus multilocularis | histone deacetylase 7 | 0.0509 | 0.0597 | 0.0597 |
Echinococcus granulosus | histone deacetylase 6 | 0.0521 | 0.0648 | 0.0648 |
Echinococcus granulosus | histone deacetylase 6 | 0.0509 | 0.0597 | 0.0597 |
Loa Loa (eye worm) | histone deacetylase 1 | 0.0399 | 0.0141 | 0.0141 |
Echinococcus granulosus | histone deacetylase 6 | 0.0509 | 0.0597 | 0.0597 |
Echinococcus multilocularis | metabotropic glutamate receptor 2 | 0.1885 | 0.6319 | 0.6319 |
Trichomonas vaginalis | histone deacetylase 1, 2 ,3, putative | 0.0399 | 0.0141 | 0.5 |
Plasmodium vivax | histone deacetylase, putative | 0.0509 | 0.0597 | 1 |
Trypanosoma cruzi | histone deacetylase, putative | 0.0509 | 0.0597 | 1 |
Loa Loa (eye worm) | glutamate receptor | 0.0885 | 0.2162 | 0.2162 |
Entamoeba histolytica | histone deacetylase, putative | 0.0399 | 0.0141 | 0.5 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0399 | 0.0141 | 0.5 |
Plasmodium falciparum | histone deacetylase 2 | 0.0509 | 0.0597 | 1 |
Plasmodium vivax | histone deacetylase 2, putative | 0.0509 | 0.0597 | 1 |
Echinococcus multilocularis | metabotropic glutamate receptor 5 | 0.277 | 1 | 1 |
Echinococcus multilocularis | histone deacetylase 6 | 0.0509 | 0.0597 | 0.0597 |
Echinococcus granulosus | histone deacetylase | 0.0509 | 0.0597 | 0.0597 |
Brugia malayi | metabotropic glutamate receptor type 2 | 0.1097 | 0.3042 | 0.3881 |
Leishmania major | histone deacetylase, putative | 0.0509 | 0.0597 | 1 |
Echinococcus granulosus | histone deacetylase 3 | 0.0399 | 0.0141 | 0.0141 |
Trypanosoma brucei | histone deacetylase 3 | 0.0509 | 0.0597 | 1 |
Echinococcus multilocularis | histone deacetylase | 0.0509 | 0.0597 | 0.0597 |
Loa Loa (eye worm) | receptor family ligand binding region containing protein | 0.0577 | 0.088 | 0.088 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0399 | 0.0141 | 0.5 |
Brugia malayi | Metabotropic glutamate receptor precursor. | 0.225 | 0.7838 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0577 | 0.088 | 0.088 |
Trypanosoma cruzi | histone deacetylase, putative | 0.0509 | 0.0597 | 1 |
Plasmodium falciparum | histone deacetylase, putative | 0.0509 | 0.0597 | 1 |
Trypanosoma brucei | histone deacetylase, putative | 0.0509 | 0.0597 | 1 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0399 | 0.0141 | 0.5 |
Trypanosoma brucei | histone deacetylase 4 | 0.0509 | 0.0597 | 1 |
Trichomonas vaginalis | histone deacetylase 1, 2 ,3, putative | 0.0399 | 0.0141 | 0.5 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0399 | 0.0141 | 0.5 |
Echinococcus granulosus | histone deacetylase 1 | 0.0399 | 0.0141 | 0.0141 |
Schistosoma mansoni | histone deacetylase | 0.0399 | 0.0141 | 0.0154 |
Loa Loa (eye worm) | metabotropic GABA-B receptor subtype 2 | 0.0577 | 0.088 | 0.088 |
Loa Loa (eye worm) | histone deacetylase 7A | 0.0509 | 0.0597 | 0.0597 |
Echinococcus multilocularis | histone deacetylase 1 | 0.0399 | 0.0141 | 0.0141 |
Schistosoma mansoni | histone deacetylase 4 5 | 0.0509 | 0.0597 | 0.0654 |
Brugia malayi | Histone deacetylase family protein | 0.0509 | 0.0597 | 0.0761 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0399 | 0.0141 | 0.5 |
Giardia lamblia | Histone deacetylase | 0.0399 | 0.0141 | 0.5 |
Echinococcus multilocularis | histone deacetylase 3 | 0.0399 | 0.0141 | 0.0141 |
Schistosoma mansoni | histone deacetylase 4 5 | 0.0509 | 0.0597 | 0.0654 |
Brugia malayi | Receptor family ligand binding region containing protein | 0.0577 | 0.088 | 0.1122 |
Loa Loa (eye worm) | histone deacetylase 3 | 0.0399 | 0.0141 | 0.0141 |
Toxoplasma gondii | histone deacetylase HDAC1 | 0.0509 | 0.0597 | 1 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.1885 | 0.6319 | 0.6929 |
Loa Loa (eye worm) | hypothetical protein | 0.0399 | 0.0141 | 0.0141 |
Brugia malayi | Histone deacetylase family protein | 0.0509 | 0.0597 | 0.0761 |
Schistosoma mansoni | histone deacetylase | 0.0399 | 0.0141 | 0.0154 |
Loa Loa (eye worm) | hypothetical protein | 0.277 | 1 | 1 |
Leishmania major | histone deacetylase, putative | 0.0509 | 0.0597 | 1 |
Loa Loa (eye worm) | glutamate receptor | 0.225 | 0.7838 | 0.7838 |
Echinococcus granulosus | histone deacetylase 7 | 0.0509 | 0.0597 | 0.0597 |
Onchocerca volvulus | Metabotropic glutamate receptor homolog | 0.0365 | 0 | 0.5 |
Brugia malayi | histone deacetylase 3 (HD3) | 0.0399 | 0.0141 | 0.018 |
Brugia malayi | metabotropic glutamate receptor subtype 5a (mGluR5a), putative | 0.2039 | 0.6958 | 0.8878 |
Loa Loa (eye worm) | histone deacetylase | 0.0509 | 0.0597 | 0.0597 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | = 0.3 mg kg-1 | Ability to inhibit the intestinal absorption of [3H]-cholesterol in cholesterol-fed hamsters | ChEMBL. | 9258361 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.